Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Graham D. Y., Klein P. D., Opekun A. R., Smith K. E., Polasani R. R., Evans D. J., Jr, Evans D. G., Alpert L. C., Michaletz P. A., Yoshimura H. H. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol. 1989 Mar;84(3):233–238. [PubMed] [Google Scholar]
- Gubbins G. P., Schubert T. T., Attanasio F., Lubetsky M., Perez-Perez G. I., Blaser M. J. Helicobacter pylori seroprevalence in patients with rheumatoid arthritis: effect of nonsteroidal anti-inflammatory drugs and gold compounds. Am J Med. 1992 Oct;93(4):412–418. doi: 10.1016/0002-9343(92)90171-7. [DOI] [PubMed] [Google Scholar]
- Janssen M., Dijkmans B. A., Vandenbroucke J. P., van Duijn W., Peña A. S., Lamers C. B. Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold. Ann Rheum Dis. 1992 Sep;51(9):1036–1038. doi: 10.1136/ard.51.9.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taha A. S., Sturrock R. D., Russell R. I. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 1992 Dec;87(12):1732–1735. [PubMed] [Google Scholar]
- Taha A. S., Sturrock R. D. The gold plated stomach? Ann Rheum Dis. 1993 Feb;52(2):89–90. doi: 10.1136/ard.52.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanabe H. Pathogenesis of gastric mucosal damage induced by intraperitoneal administration of gold thioglucose in rats. Gastroenterol Jpn. 1989 Aug;24(4):357–364. doi: 10.1007/BF02774340. [DOI] [PubMed] [Google Scholar]